Bangladesh – pharmaceutical daily

December 19, 2016 Off

Bangladesh-based drugmaker gets FDA’s approval for its generic Bristol-Myers’s diabetes tablets

Bangladesh-based drugmaker Beximco has received approval for its Bristol-Myers Squibb’s (BMS) generic equivalent Glucophage XR tablets, Metformin from the US…

October 25, 2016 Off

Bangladesh’s Beximco gets its second US FDA product approval

By Dino Mustafić

Bangladesh-based Beximco, the largest country’s pharmaceutcals exporter, has received its second US FDA …

October 19, 2016 Off

Beximco Pharmaceutical to declare cash and stock dividends at next AGM

By Dino Mustafić

A Bangladesh based, AIM listed Beximco Pharmaceuticals has announced that it would declare/approve 5% final Cash Dividend, 5% Stock Dividend and 10% Cash Dividend